Corn prices fall to lowest level in 3 years

Aug 18, 2023

In Chicago, the corn market saw a big drop, reaching prices like those in 2020. The cause is an improvement in the weather, leading to enhanced crop conditions across the US.

A 2.9% decline saw the benchmark futures stoop to their lowest since December 2020. These optimistic weather conditions have brightened the horizon for a potential bumper harvest, regardless of the USDA's recent adjustment in the crop's estimated size from its record peak to being the second largest.

Shedding light on this scenario is Susan David from No Bull Ag in St. Louis. "The saying goes 'Rain makes grain', and when paired with cooler temperatures, it’s a winning combination for grain growth," she comments. Speaking about the year's trajectory for corn, she adds, "The start of 2023 was rocky for corn, but Mother Nature's recent cool and damp touch has reversed early losses."

This year has recorded a drop of about 21% in corn's market price. This dip comes in anticipation of a fruitful harvest season in the US. Adding to this sentiment is Brazil, which is currently during a record-breaking corn harvest.

Source : wisconsinagconnection

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.